Isolation and characterization of mpox virus from the first mpox case in Shenzhen, China

Abstract

Electronic Supplementary Material

10.1016j.virs.2024.01.004-ESM.doc

References

1. Gong Q, Wang C, Chuai X, Chiu S. 2022. Monkeypox virus:A re-emergent threat to humans. Virol Sin, 37:477-482.
   

2. Huang B, Zhao H, Song J, Zhao L, Deng Y, Wang W, Lu R, Wang W, Ren J, Ye F, Tian H, Wu G, Ling H, Tan W. 2022. Isolation and characterization of monkeypox virus from the first case of monkeypox-chongqing municipality, china, 2022. China CDC Wkly, 4:1019-1024.
   

3. Jia H, Sha T, Zhao S, Su W, Liu P, Zhen R, Li P, Zhou L, Xu Y, Wen Y, Chi L, Di B, Li P, Chen H, Qin P. 2023. Genomic and epidemiological perspectives on the first local sporadic cases of mpox in china. Emerg Microbes Infect, 12:2245932.
   

4. Ju B, Zhang Q, Ge J, Wang R, Sun J, Ge X, Yu J, Shan S, Zhou B, Song S, Tang X, Yu J, Lan J, Yuan J, Wang H, Zhao J, Zhang S, Wang Y, Shi X, Liu L, Zhao J, Wang X, Zhang Z, Zhang L. 2020. Human neutralizing antibodies elicited by sars-cov-2 infection. Nature, 584:115-119.
   

5. Li M, Ren Z, Wang Y, Jiang Y, Yang M, Li D, Chen J, Liang Z, Lin Y, Zeng Z, Xu R, Wang Y, Zhu L, Xiao W, Wu Q, Zhang B, Wan C, Yang Y, Wu B, Peng J, Zhao W, Shen C. 2023. Three neutralizing mabs induced by mpxv a29l protein recognizing different epitopes act synergistically against orthopoxvirus. Emerg Microbes Infect, 12:2223669.
   

6. Lustig S, Fogg C, Whitbeck JC, Moss B. 2004. Synergistic neutralizing activities of antibodies to outer membrane proteins of the two infectious forms of vaccinia virus in the presence of complement. Virology, 328:30-35.
   

7. Payne LG. 1979. Identification of the vaccinia hemagglutinin polypeptide from a cell system yielding large amounts of extracellular enveloped virus. J Virol, 31:147-155.
   

8. Russo AT, Grosenbach DW, Chinsangaram J, Honeychurch KM, Long PG, Lovejoy C, Maiti B, Meara I, Hruby DE. 2021. An overview of tecovirimat for smallpox treatment and expanded anti-orthopoxvirus applications. Expert Rev Anti Infect Ther, 19:331-344.
   

9. Sun S, Cai Y, Song TZ, Pu Y, Cheng L, Xu H, Sun J, Meng C, Lin Y, Huang H, Zhao F, Zhang S, Gao Y, Han JB, Feng XL, Yu DD, Zhu Y, Gao P, Tang H, Zhao J, Zhang Z, Yang J, Hu Z, Fu YX, Zheng YT, Peng H. 2021. Interferon-armed rbd dimer enhances the immunogenicity of rbd for sterilizing immunity against sars-cov-2. Cell Res, 31:1011-1023.
   

10. Yang L, Chen Y, Li S, Zhou Y, Zhang Y, Pei R, Chen X, Wang Y. 2023. Immunization of mice with vaccinia virus tiantan strain yields antibodies cross-reactive with protective antigens of monkeypox virus. Virol Sin, 38:162-164.
    

11. Zhang RR, Wang ZJ, Zhu YL, Tang W, Zhou C, Zhao SQ, Wu M, Ming T, Deng YQ, Chen Q, Jin NY, Ye Q, Li X, Qin CF. 2023. Rational development of multicomponent mrna vaccine candidates against mpox. Emerg Microbes Infect, 12:2192815.
    

12. Zhou B, Wang H, Cheng L, Zhao C, Zhou X, Liao X, Ge X, Liu L, Lu X, Ju B, Zhang Z. 2023. Two long-lasting human monoclonal antibodies cross-react with monkeypox virus a35 antigen. Cell Discov, 9:50.
    

Proportional views